SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-000710
Filing Date
2023-01-09
Accepted
2023-01-09 06:39:26
Documents
50
Period of Report
2023-01-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gthx-20230109.htm   iXBRL 8-K 37248
2 EX-99.1 a2023jpmfinal2022-01x06.htm EX-99.1 46128
6 a2023jpmfinal2022-01x06001.jpg GRAPHIC 85488
7 a2023jpmfinal2022-01x06002.jpg GRAPHIC 196054
8 a2023jpmfinal2022-01x06003.jpg GRAPHIC 128436
9 a2023jpmfinal2022-01x06004.jpg GRAPHIC 164340
10 a2023jpmfinal2022-01x06005.jpg GRAPHIC 129485
11 a2023jpmfinal2022-01x06006.jpg GRAPHIC 140154
12 a2023jpmfinal2022-01x06007.jpg GRAPHIC 116208
13 a2023jpmfinal2022-01x06008.jpg GRAPHIC 75423
14 a2023jpmfinal2022-01x06009.jpg GRAPHIC 128307
15 a2023jpmfinal2022-01x06010.jpg GRAPHIC 112353
16 a2023jpmfinal2022-01x06011.jpg GRAPHIC 116448
17 a2023jpmfinal2022-01x06012.jpg GRAPHIC 111227
18 a2023jpmfinal2022-01x06013.jpg GRAPHIC 109812
19 a2023jpmfinal2022-01x06014.jpg GRAPHIC 119818
20 a2023jpmfinal2022-01x06015.jpg GRAPHIC 127795
21 a2023jpmfinal2022-01x06016.jpg GRAPHIC 113204
22 a2023jpmfinal2022-01x06017.jpg GRAPHIC 119918
23 a2023jpmfinal2022-01x06018.jpg GRAPHIC 114223
24 a2023jpmfinal2022-01x06019.jpg GRAPHIC 77827
25 a2023jpmfinal2022-01x06020.jpg GRAPHIC 107998
26 a2023jpmfinal2022-01x06021.jpg GRAPHIC 118423
27 a2023jpmfinal2022-01x06022.jpg GRAPHIC 161006
28 a2023jpmfinal2022-01x06023.jpg GRAPHIC 112868
29 a2023jpmfinal2022-01x06024.jpg GRAPHIC 112408
30 a2023jpmfinal2022-01x06025.jpg GRAPHIC 114074
31 a2023jpmfinal2022-01x06026.jpg GRAPHIC 81934
32 a2023jpmfinal2022-01x06027.jpg GRAPHIC 120060
33 a2023jpmfinal2022-01x06028.jpg GRAPHIC 74811
34 a2023jpmfinal2022-01x06029.jpg GRAPHIC 140849
35 a2023jpmfinal2022-01x06030.jpg GRAPHIC 81436
36 a2023jpmfinal2022-01x06031.jpg GRAPHIC 93537
37 a2023jpmfinal2022-01x06032.jpg GRAPHIC 145648
38 a2023jpmfinal2022-01x06033.jpg GRAPHIC 110871
39 a2023jpmfinal2022-01x06034.jpg GRAPHIC 67608
40 a2023jpmfinal2022-01x06035.jpg GRAPHIC 114354
41 a2023jpmfinal2022-01x06036.jpg GRAPHIC 84150
42 a2023jpmfinal2022-01x06037.jpg GRAPHIC 106284
  Complete submission text file 0001628280-23-000710.txt   6078526

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gthx-20230109.xsd EX-101.SCH 1920
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gthx-20230109_lab.xml EX-101.LAB 24849
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gthx-20230109_pre.xml EX-101.PRE 13058
44 EXTRACTED XBRL INSTANCE DOCUMENT gthx-20230109_htm.xml XML 11842
Mailing Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709
Business Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Filer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38096 | Film No.: 23516457
SIC: 2834 Pharmaceutical Preparations